1. Dr. Paul M. Matthews. Experte für Multiple Sklerose und Gehirn-MRT. Biografie. 0
Dr. Paul M. Matthews, MD, explains his distinguished career in translational neuroscience. He holds prestigious academic and research leadership positions at Imperial College London.
▶⏸
2. Multiple Sklerose. Wie der Verlust von Neuronen die Prognose beeinflusst. 1
Dr. Paul Matthews, MD, explains how axonal and neuronal loss drives disease progression. He details the paradigm-shifting research that redefined MS as a neurodegenerative condition....
▶⏸
3. Behandlung von Multipler Sklerose. Rituximab, Quilizimab, Lymphgefäße des Gehirns Teil 1 von 3. 7
Dr. Paul Matthews, MD, explains recent breakthroughs in personalized medicine. He highlights the landmark rituximab trial that transformed MS immunology by targeting B-cells.
▶⏸
4. Multiple Sklerose Diagnose und Prognose. Gehirn-MRT und PET-CT. Teil 1 von 2. 11
Dr. Paul Matthews, MD, explains how advanced MRI and PET CT technologies are revolutionizing diagnosis and prognosis. He details the use of optical coherence tomography...
▶⏸
5. Multiple Sklerose im Frühstadium. Neurodegeneration und Fortschreiten zur Behinderung. Teil 1. 2
Dr. Paul Matthews, MD, explains how axonal loss begins early in MS and drives permanent disability. He details how MRI techniques can measure brain volume...
▶⏸
6. Behandlung von Multipler Sklerose. Neuromyelitis optica. Tysabri. Präzisionsmedizin. Teil 2 von 3. 8
Dr. Paul Matthews, MD, explains major breakthroughs in personalized medicine for MS. He details how genetic research confirmed MS as a primary autoimmune disease.
▶⏸
7. Multiple Sklerose Diagnose und Prognose. Antikörperbasierte MRT. Quantitative MRT. Teil 2 von 2. 12
Dr. Paul Matthews, MD, explains how MRI technology is rapidly evolving. He details advancements in speed, sensitivity, and novel contrast agents.
▶⏸
8. Multiple Sklerose im Frühstadium. Neurodegeneration und Fortschreiten zur Behinderung. Teil 2. 3
Dr. Paul Matthews, MD, explains how early brain damage in MS does not immediately cause disability. He details the brain's remarkable capacity for adaptive repair...
▶⏸
9. Multiple Sklerose-Typen. Neuromyelitis optica (NMO). Syndrompräsentationen. Teil 1. 4
Dr. Paul Matthews, MD, explains the heterogeneity of multiple sclerosis as a clinical syndrome. He details how patients experience vastly different disease courses, from benign...
▶⏸
10. Multiple Sklerose-Typen. Neuromyelitis optica (NMO). Syndrompräsentationen. Teil 2. 5
Dr. Paul Matthews, MD, explains how neuromyelitis optica (NMO) was redefined as a distinct disease from MS. He details the role of the Aquaporin-4 antibody...
▶⏸
11. Multiple Sklerose. Erholung vom Rückfall. Wie kann man die neurologische Funktion verbessern? 6
Dr. Paul Matthews, MD, explains how neurological function recovers after a relapse. He details the brain's remarkable plasticity and redundancy. Recovery mechanisms include neuronal repair,...
▶⏸
12. Erste Symptome von Multipler Sklerose. Was bedeutet das Erkrankungsalter für die Behandlung und Prognose von Multipler Sklerose? 10
Dr. Paul Matthews, MD, explains how age of onset impacts disease progression and treatment. His sophisticated MRI analysis reveals older patients experience more aggressive neurodegeneration....
▶⏸
13. Behandlung von Multipler Sklerose. 11 neue Vermittlungen. Aber wie wählt man die richtige Mediation? Teil 3 von 3. 9
Dr. Paul Matthews, MD, explains how personalized medicine is advancing treatment. He details the importance of real-world clinical effectiveness research.
▶⏸
14. Patient-Arzt-Beziehung im Zeitalter der Präzisionsmedizin. 13
Dr. Paul Matthews, MD, explains the evolution of the patient-doctor relationship. He details the shift from a service model to a collaborative partnership.
▶⏸
15. Stratifizierte Medizin. Präzisionsmedizin für die beste Behandlung von Multipler Sklerose. Einschätzung der Prognose. 14
Dr. Paul Matthews, MD, explains how stratified medicine improves treatment. He details how grouping patients by disease characteristics and prognosis informs therapy choices.
▶⏸
16. Präzisionspharmakologie. Arzneimittelentdeckung. Personalisierte Behandlung von Multipler Sklerose. fünfzehn
Dr. Paul Matthews, MD, explains how precision pharmacology revolutionizes drug development. He details the concept of targeting the right molecule at the right time and...
Verfeinern Sie Ihren Behandlungsplan bis zur Perfektion durch ein Gremium von 3 bis 10+ Top-Ärzten, die perfekt für Sie sind.
